Priv.-Doz. Dr. Razvan Galalae

Study of medicine at the University of Hamburg with medical degree (Nov. 1989)

MedAustron

Chief physician of the Clinic for Radiooncology at the Evangelical Clinics Gelsenkirchen

Deputy director of the Clinic for Radiotherapy of the Ruhr University Bochum

Certificate in radiation protection for particle therapy

Specialization Proton Therapy Center RPTC Munich + Senior Scientist and Senior Consultant at the Paul Scherrer Institute Proton Therapy Center in Villigen/Switzerland

Deputy director of the Clinic for Radiotherapy, Kiel University Hospital

Habilitation in radiotherapy – teaching qualification (July 2005) + Venia Legendi (July 2005), Christian-Albrecht-University at Kiel

Specialist doctor in radiotherapy, Christian-Albrechts-University of Kiel

Doctor degree (Magna cum laude), Christian-Albrechts-University of Kiel

Approbation

Founding member of DEGRO (German Society for Radiooncology)

ESTRO (European Society for Radiotherapy and Oncology)

ASTRO (American Society for Radiotherapy and Oncology)

PTCOG (Particle Therapy Co-Operative Group)

Active member of the EORTC Quality of Life Group

Active member of the GEC-ESTRO (European Brachytherapy Society), Breast Cancer Working Group

Pelak MJ, Flechl B, Mumot M, Galalae R, Tubin S, Hug E, Lütgendorf-Caucig C (2021) The value of SSTR2 receptor-targeted PET/CT in proton irradiation of grade I meningioma. Cancers; Sept. 2021 in press (manuscript ID: cancers-1343510)

Greimel E, Nagele E, Lanceley A, et al. EORTC Quality of Life Group. (2021) Psychometric validation of the European Organization for Research and Treatment of Cancer – Quality of Life Questionnaire Sexual health (EORTC QLQ-SH22).
Eur J Cancer 2021; 154(2): 235-245.

Singer S, Hammerlid E, Tomaszewska IM, et al. EORTC Quality of Life Group and the EORTC Head and Neck Cancer Group. (2021) Methodological approach for determining the Minimal Important Difference Change scores for the Performance of the European Organisation for Research and Treatment of Cancer Head and Neck Module (EORTC QLQ-HN43) exemplified by the Swallowing scale.
Qual Life Res Epub 05 July 2021

Tharavichitkul E, Muangwong P, Chakrabandhu S, et al. (2021) Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound.
Brachytherapy, 20(3): 543-549.

Hannoun-Lévi JM, Gal J, Van Limbergen E, et al. (2021) Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database.
Int J Radiat Oncol Biol Phys, 110(2): 452-461.

Domankevich V, Efrati M, Schmidt M, et al. (2020) RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice.
Front Oncol. 2020 Jul 17; 10:990. doi: 10.3389/fonc.2020.00990. eCollection 2020.

Murakami N, Nakamura S, Kashihara T, Kato T, et al. (2020) Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies.
Brachytherapy. 2020 Mar-Apr; 19(2):154-161.

Galalae R, Hannoun-Lévi JM. (2020) Accelerated partial breast irradiation by brachytherapy: present evidence and future developments. (On invitation of the Japanese Society of Oncology)
Jpn J Clin Oncol. 2020 Jul 9; 50(7):743-752.